Documentation Centre

 

 

  of 5464 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Non-alcoholic fatty liver disease and risk of cardiovascular disease. Metabolism. 2016;65:1136-50 August 26, 2016 Non-alcoholic fatty liver disease and risk of cardiovascular disease. Metabolism. 2016;65:1136-50 Lonardo A, Sookoian S, Pirola CJ, Targher G Key Publications
Exercise and diet in the management of nonalcoholic fatty liver disease. Metabolism. 2016;65:1172-82 August 26, 2016 Exercise and diet in the management of nonalcoholic fatty liver disease. Metabolism. 2016;65:1172-82 Mahady SE, George J. Key Publications
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016;37:1944-58 August 26, 2016 Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016;37:1944-58 Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, Bruckert E et al. Key Publications
Adipokines in nonalcoholic fatty liver disease. Metabolism. 2016;65:1062-79 August 25, 2016 Adipokines in nonalcoholic fatty liver disease. Metabolism. 2016;65:1062-79 Polyzos SA, Kountouras J, Mantzoros CS Key Publications
Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism. 2016;65:1109-23 August 25, 2016 Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism. 2016;65:1109-23 Katsiki N, Mikhailidis DP, Mantzoros CS Key Publications
Non-alcoholic fatty liver disease and diabetes. Metabolism. 2016;65:1096-108 August 25, 2016 Non-alcoholic fatty liver disease and diabetes. Metabolism. 2016;65:1096-108 Hazlehurst JM, Woods C, Marjot T, Cobbold JF, Tomlinson JW Key Publications
Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism. 2016;65:1017-25 August 24, 2016 Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism. 2016;65:1017-25 Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM Key Publications
Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. Metabolism. 2016;65:1049-61 August 24, 2016 Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. Metabolism. 2016;65:1049-61 Mota M, Banini BA, Cazanave SC, Sanyal AJ. Key Publications
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65:1038-48 August 24, 2016 The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65:1038-48 Buzzetti E, Pinzani M, Tsochatzis EA Key Publications
2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: A report of the American College of Cardiology task force on clinical expert consensus documents. J Am Coll Cardiol. 2016;68:92-125 August 23, 2016 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: A report of the American College of Cardiology task force on clinical expert consensus documents. J Am Coll Cardiol. 2016;68:92-125 Writing Committee, Lloyd-Jones DM, Morris PB, Ballantyne CM, Birtcher KK, Daly DD Jr, DePalma SM, Minissian MB, Orringer CE, Smith SC Jr Key Publications

  of 5464 Next page

Go to page: of